<VariationArchive VariationID="1452627" VariationName="NM_000218.3(KCNQ1):c.771_775dup (p.Arg259fs)" VariationType="Duplication" Accession="VCV001452627" Version="9" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1364346" VariationID="1452627">
      <GeneList>
        <Gene Symbol="KCNQ1" FullName="potassium voltage-gated channel subfamily Q member 1" GeneID="3784" HGNC_ID="HGNC:6294" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.5-15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2445008" stop="2849105" display_start="2445008" display_stop="2849105" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NT_187585.1" start="1031" stop="81270" display_start="1031" display_stop="81270" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2466220" stop="2870339" display_start="2466220" display_stop="2870339" Strand="+" />
          </Location>
          <OMIM>607542</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000218.3(KCNQ1):c.771_775dup (p.Arg259fs)</Name>
      <CanonicalSPDI>NC_000011.10:2572099:CCACC:CCACCCCACC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11p15.5</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2572099" stop="2572100" display_start="2572099" display_stop="2572100" variantLength="5" positionVCF="2572099" referenceAlleleVCF="T" alternateAlleleVCF="TCCACC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2593329" stop="2593330" display_start="2593329" display_stop="2593330" variantLength="5" positionVCF="2593329" referenceAlleleVCF="T" alternateAlleleVCF="TCCACC" />
      </Location>
      <ProteinChange>R132fs</ProteinChange>
      <ProteinChange>R259fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_287" sequenceAccession="LRG_287">
            <Expression>LRG_287:g.132110_132114dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_287t1" sequenceAccession="LRG_287t1">
            <Expression>LRG_287t1:c.771_775dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_287p1" sequenceAccession="LRG_287p1" change="p.Arg259Profs">
            <Expression>LRG_287p1:p.Arg259Profs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_287t2" sequenceAccession="LRG_287t2">
            <Expression>LRG_287t2:c.390_394dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_287p2" sequenceAccession="LRG_287p2" change="p.Arg132fs">
            <Expression>LRG_287p2:p.Arg132fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.2572100_2572104dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.2572100_2572104dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.2593330_2593334dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.2593330_2593334dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008935.1" sequenceAccession="NG_008935" sequenceVersion="1" change="g.132110_132114dup">
            <Expression>NG_008935.1:g.132110_132114dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000218.3" sequenceAccession="NM_000218" sequenceVersion="3" change="c.771_775dup" MANESelect="true">
            <Expression>NM_000218.3:c.771_775dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000209.2" sequenceAccession="NP_000209" sequenceVersion="2" change="p.Arg259fs">
            <Expression>NP_000209.2:p.Arg259fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406836.1" sequenceAccession="NM_001406836" sequenceVersion="1" change="c.771_775dup">
            <Expression>NM_001406836.1:c.771_775dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393765.1" sequenceAccession="NP_001393765" sequenceVersion="1" change="p.Arg259Profs">
            <Expression>NP_001393765.1:p.Arg259Profs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406837.1" sequenceAccession="NM_001406837" sequenceVersion="1" change="c.501_505dup">
            <Expression>NM_001406837.1:c.501_505dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393766.1" sequenceAccession="NP_001393766" sequenceVersion="1" change="p.Arg169Profs">
            <Expression>NP_001393766.1:p.Arg169Profs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181798.2" sequenceAccession="NM_181798" sequenceVersion="2" change="c.390_394dup">
            <Expression>NM_181798.2:c.390_394dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861463.1" sequenceAccession="NP_861463" sequenceVersion="1" change="p.Arg132Profs">
            <Expression>NP_861463.1:p.Arg132Profs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_040711.2" sequenceAccession="NR_040711" sequenceVersion="2" change="n.664_668dup">
            <Expression>NR_040711.2:n.664_668dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2133730742" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.771_775dup (p.Arg259fs) AND Long QT syndrome" Accession="RCV002037701" Version="7">
        <ClassifiedConditionList TraitSetID="8775">
          <ClassifiedCondition DB="MedGen" ID="C0023976">Long QT syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.771_775dup (p.Arg259fs) AND multiple conditions" Accession="RCV003458177" Version="1">
        <ClassifiedConditionList TraitSetID="12758">
          <ClassifiedCondition DB="MedGen" ID="C1837014">Atrial fibrillation, familial, 3</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551509">Jervell and Lange-Nielsen syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551647">Long QT syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1865019">Short QT syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19716085</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19862833</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9323054</ID>
        </Citation>
        <DescriptionHistory Dated="2023-12-23">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8775" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16506" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome</ElementValue>
                <XRef ID="Long+QT+Syndrome/4296" DB="Genetic Alliance" />
                <XRef ID="HP:0001657" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0002442" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS192500" DB="OMIM" />
                <XRef ID="9651007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQTS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LQT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Various modes of inheritance</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000511116" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520456" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528500" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552174" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592276" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515873" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519089" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520446" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523361" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591169" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528497" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000559512" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520458" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522200" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000555634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558315" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C0023976" DB="MedGen" />
              <XRef ID="D008133" DB="MeSH" />
              <XRef ID="MONDO:0002442" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12758" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5908" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Short QT syndrome type 2</ElementValue>
                <XRef ID="MONDO:0012313" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SQT2</ElementValue>
                <XRef Type="MIM" ID="609621" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18634" />
                <XRef ID="18634" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <XRef ID="51083" DB="Orphanet" />
              <XRef ID="C1865019" DB="MedGen" />
              <XRef ID="MONDO:0012313" DB="MONDO" />
              <XRef Type="MIM" ID="609621" DB="OMIM" />
            </Trait>
            <Trait ID="2703" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 1</ElementValue>
                <XRef ID="Long+QT+syndrome+1/4297" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008646" DB="MONDO" />
                <XRef ID="MONDO:0100316" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT1</ElementValue>
                <XRef ID="GTR000558497" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="192500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3284" />
                <XRef ID="3284" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C4551647" DB="MedGen" />
              <XRef ID="MONDO:0100316" DB="MONDO" />
              <XRef Type="MIM" ID="192500" DB="OMIM" />
            </Trait>
            <Trait ID="5349" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness, congenital, and functional heart disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Prolonged QT interval in EKG and sudden death</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardioauditory syndrome of Jervell and Lange-Nielsen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Surdo-cardiac syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Jervell and Lange-Nielsen syndrome 1</ElementValue>
                <XRef ID="MONDO:0024540" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JLNS1</ElementValue>
                <XRef Type="MIM" ID="220400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Jervell and Lange-Nielsen Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &gt;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.</Attribute>
                <XRef ID="NBK1405" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301579</ID>
                <ID Source="BookShelf">NBK1405</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="90647" DB="Orphanet" />
              <XRef ID="C4551509" DB="MedGen" />
              <XRef ID="MONDO:0024540" DB="MONDO" />
              <XRef Type="MIM" ID="220400" DB="OMIM" />
            </Trait>
            <Trait ID="562" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Atrial fibrillation, familial, 3</ElementValue>
                <XRef ID="Atrial+fibrillation%2C+familial%2C+3/7734" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011857" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATFB3</ElementValue>
                <XRef Type="MIM" ID="607554" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15414" />
                <XRef ID="15414" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng196</URL>
                <CitationText>UK NICE Guideline NG196, Atrial fibrillation: diagnosis and management, 2021</CitationText>
              </Citation>
              <XRef ID="C1837014" DB="MedGen" />
              <XRef ID="MONDO:0011857" DB="MONDO" />
              <XRef Type="MIM" ID="607554" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7829849" SubmissionDate="2023-11-30" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="Chr11:2593329" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004190162" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Division Of Personalized Genomic Medicine, Columbia University Irving Medical Center" OrgID="508215" OrganizationCategory="laboratory" OrgAbbreviation="PGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This variant is a 5 base pair duplication at nucleotides c.771_775 in exon 5 of 16 of the KCNQ1 gene, resulting in the_x000D_substitution of the arginine at amino acid position 259 to a proline and a reading frame shift causing premature _x000D_termination of translation six amino acid residues downstream (p.Arg259Profs*6). This variant is expected to result in _x000D_nonsense mediated decay. Loss-of-function variants in KCNQ1 have been established to be pathogenic (PMID:_x000D_19862833). Several loss-of-function variants downstream to this variant have been reported in the literature and in the_x000D_ ClinVar database as pathogenic. This variant is absent in the Genome Aggregation Database (gnomAD), indicating it is_x000D_ not a common benign variant in the populations represented in this database. To the best of our knowledge,_x000D_this exact variant has not been described to be disease associated in literature.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>South East Asian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <Purpose>validation</Purpose>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0100021" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.3:c.771_775dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607554" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220400" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609621" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14009349</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4245730" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4889195|MedGen:C0023976" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002233184" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9323054</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19862833</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19716085</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg259Profs*6) in the KCNQ1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KCNQ1 are known to be pathogenic (PMID: 9323054, 19862833). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of KCNQ1-related conditions (PMID: 19716085). This variant is also known as 776_780dupCCACC. ClinVar contains an entry for this variant (Variation ID: 1452627). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.2593329_2593330insCCACC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023976" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7829849" TraitType="Disease" MappingType="XRef" MappingValue="192500" MappingRef="OMIM">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7829849" TraitType="Disease" MappingType="XRef" MappingValue="220400" MappingRef="OMIM">
        <MedGen CUI="C4551509" Name="Jervell and Lange-Nielsen syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7829849" TraitType="Disease" MappingType="XRef" MappingValue="609621" MappingRef="OMIM">
        <MedGen CUI="C1865019" Name="Short QT syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7829849" TraitType="Disease" MappingType="XRef" MappingValue="607554" MappingRef="OMIM">
        <MedGen CUI="C1837014" Name="Atrial fibrillation, familial, 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4245730" TraitType="Disease" MappingType="XRef" MappingValue="C0023976" MappingRef="MedGen">
        <MedGen CUI="C0023976" Name="Long QT syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7829849" TraitType="Finding" MappingType="XRef" MappingValue="HP:0100021" MappingRef="HP">
        <MedGen CUI="C0007789" Name="Cerebral palsy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

